Sandbox/AL

Jump to navigation Jump to search

Pathogen-Based Therapy — Bacteria Adapted from

▸ Click on the following categories to expand treatment regimens.

Bacteria

  ▸  Staphylococcus aureus

  ▸  Staphylococcus epidermidis

  ▸  Methicillin-resistant S. aureus

  ▸  Streptococcus groups A, B, C, G

  ▸  Enterococcus feacalis

Staphylococcus aureus
Preferred Regimen
Nafcillin 2 g IV q6h
Alternative Regimen
Vancomycin
OR
Cefazolin
OR
Clindamycin
Staphylococcus epidermidis
Preferred Regimen
Vancomycin 15 mg/kg IV q12h
Alternative Regimen
TMP-SMX
OR
Methicillin-resistant S. aureus
Preferred Regimen
Vancomycin 15 mg/kg IV q12h
Alternative Regimen
TMP-SMX
OR
Doxycycline'
OR
Linezolid
{| class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table21" style="background: #FFFFFF;"
Listeria monocytogenes
Preferred Regimen
Ampicillin 2 g IV q4h
OR
Penicillin G 4 MU IV q4h
PLUS
Gentamicin 1.7 mg/kg IV q8h
Alternative Regimen
TMP/SMZ 5 mg/kg IV q6—12h (TMP component)
N. meningitidis, Penicillin MIC <0.1 μg/mL
Preferred Regimen
Penicillin G 4 MU IV q4h
OR
Ampicillin 2 g IV q4h
Alternative Regimen
Cefotaxime 2 g IV q4—6h
OR
Ceftriaxone 2 g IV q12h
OR
Chloramphenicol 1—1.5 g IV q6h
N. meningitidis, Penicillin MIC ≥0.1 μg/mL
Preferred Regimen
Cefotaxime 2 g IV q4—6h
OR
Ceftriaxone 2 g IV q12h
Alternative Regimen
Cefepime 2 g IV q8h
OR
Chloramphenicol 1—1.5 g IV q6h
OR
Moxifloxacin 400 mg IV q24h
OR
Meropenem 2 g IV q8h
Pseudomonas aeruginosa
Preferred Regimen
Ceftazidime 2 g IV q8h
OR
Cefepime 2 g IV q8h
PLUS
Gentamicin 1.7 mg/kg IV q8h
Alternative Regimen
Aztreonam 2 g IV q6—8h
OR
Meropenem 2 g IV q8h
OR
Ciprofloxacin 400 mg IV q8—12h
PLUS
Gentamicin 1.7 mg/kg IV q8h
Staphylococcus aureus, Methicillin sensitive
Preferred Regimen
Nafcillin 1.5—2 g IV q4h
OR
Oxacillin 1.5—2 g IV q4h
Alternative Regimen
Vancomycin 15 mg/kg IV q6h (trough 15—20 μg/mL)
OR
Linezolid 600 mg IV q12h
OR
Daptomycin 6 mg/kg IV q24h
Staphylococcus aureus, Methicillin resistant
Preferred Regimen
Vancomycin 15 mg/kg IV q6h (trough 15—20 μg/mL)
PLUS
Rifampin 600 mg IV q24h
Alternative Regimen
TMP/SMZ 5 mg/kg IV q6—12h (TMP component)
OR
Linezolid 600 mg IV q12h
OR
Daptomycin 6 mg/kg IV q24h
PLUS
Rifampin 600 mg IV q24h
Staphylococcus epidermidis
Preferred Regimen
Vancomycin 15 mg/kg IV q6h (trough 15—20 μg/mL)
PLUS
Rifampin 600 mg IV q24h
Alternative Regimen
Linezolid 600 mg IV q12h
PLUS
Rifampin 600 mg IV q24h
Streptococcus agalactiae
Preferred Regimen
Ampicillin 2 g IV q4h
OR
Penicillin G 4 MU IV q4h
PLUS
Gentamicin 1.7 mg/kg IV q8h
Alternative Regimen
Cefotaxime 2 g IV q4—6h
OR
Ceftriaxone 2 g IV q12h
OR
Vancomycin 15 mg/kg IV q6h (trough 15—20 μg/mL)
S. pneumoniae, Penicillin MIC ≤0.06 μg/mL
Preferred Regimen
Penicillin G 4 MU IV q4h
OR
Ampicillin 2 g IV q4h
Alternative Regimen
Cefotaxime 2 g IV q4—6h
OR
Ceftriaxone 2 g IV q12h
OR
Chloramphenicol 1—1.5 g IV q6h
S. pneumoniae, Penicillin MIC ≥0.12 μg/mL, Cefotaxime/Ceftriaxone MIC <1.0 μg/mL
Preferred Regimen
Cefotaxime 2 g IV q4—6h
OR
Ceftriaxone 2 g IV q12h
Alternative Regimen
Cefepime 2 g IV q8h
OR
Meropenem 2 g IV q8h
S. pneumoniae, Penicillin MIC ≥0.12 μg/mL, Cefotaxime/Ceftriaxone MIC ≥1.0 μg/mL
Preferred Regimen
Vancomycin 15 mg/kg IV q6h (trough 15—20 μg/mL)
PLUS
Cefotaxime 2 g IV q4—6h
OR
Ceftriaxone 2 g IV q12h
PLUS
Rifampin 600 mg IV q24h
Alternative Regimen
Vancomycin 15 mg/kg IV q6h (trough 15—20 μg/mL)
PLUS
Moxifloxacin 400 mg IV q24h
Mycobacterium tuberculosis (New Patients)
Intensive Phase
Isoniazid 5 mg/kg PO qd × 2 months
OR
Isoniazid 10 mg/kg PO 3 times per week × 2 months
PLUS
Rifampicin 10 mg/kg PO qd × 2 months
OR
Rifampicin 10 mg/kg PO 3 times per week × 2 months
PLUS
Pyrazinamide 25 mg/kg PO qd × 2 months
OR
Pyrazinamide 35 mg/kg PO 3 times per week × 2 months
PLUS
Streptomycin 15 mg/kg PO qd × 2 months
OR
Streptomycin 15 mg/kg PO 3 times per week × 2 months
Continuation Phase
Isoniazid 5 mg/kg PO qd × 4 months
OR
Isoniazid 10 mg/kg PO 3 times per week × 2 months
PLUS
Rifampicin 10 mg/kg PO qd × 4 months
OR
Rifampicin 10 mg/kg PO 3 times per week × 2 months
Adapted from Treatment of Tuberculosis: Guidelines.[1]
Borrelia burgdorferi
Preferred Regimen
Ceftriaxone 2 g IV q24h × 10—28 days
Alternative Regimen
Cefotaxime 2 g IV q8h × 10—28 days
OR
Penicillin G 3—4 MU IV q4h × 10—28 days
OR
Doxycycline 100—200 mg PO q12h × 10—28 days
Adapted from Clin Infect Dis. 2006;43(9):1089-134.[2]
Treponema pallidum
Preferred Regimen
Penicillin G 3—4 MU IV q4h × 10—14 days
Alternative Regimen
Procaine penicillin 2.4 MU IM q24h × 10—14 days
PLUS
Probenecid 500 mg PO q6h × 10—14 days
Adapted from MMWR Recomm Rep. 2006;55(RR-11):1-94.[3]

|}

  1. Treatment of tuberculosis : guidelin. Geneva: World Health Organization. 2010. ISBN 978-92-4-154783-3.
  2. Wormser, GP.; Dattwyler, RJ.; Shapiro, ED.; Halperin, JJ.; Steere, AC.; Klempner, MS.; Krause, PJ.; Bakken, JS.; Strle, F. (2006). "The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America". Clin Infect Dis. 43 (9): 1089–134. doi:10.1086/508667. PMID 17029130. Unknown parameter |month= ignored (help)
  3. Workowski, KA.; Berman, SM. (2006). "Sexually transmitted diseases treatment guidelines, 2006". MMWR Recomm Rep. 55 (RR-11): 1–94. PMID 16888612. Unknown parameter |month= ignored (help)